An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...

The way women experience health and disease are unique through specific stages like pregnancy, menopause and more.

Accredo employs more than 800 specialty pharmacists who are dedicated to educating and assisting patients with rare or complex conditions.

In this episode of the Health Unscripted Podcast, Matt Perlberg, president of the Evernorth Health Services pharmacy businesses, sits down with Vicki Wheeler, chief operating officer of Evernorth's ph...

Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...

The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.